Exogene
Biotechnology ResearchUnited Kingdom11-50 Employees
Exogene is an Oxford-based, venture-backed biotechnology company using a proprietary lab-in-the-loop AI platform to design novel, multi-specific immune engager drugs targeting peptide-HLA antigens to eradicate cancer.